Divergent cardiac effects of the first and second generation hypoglycemic sulfonylurea compounds.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Diabetes Research and Clinical Practice

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0168-8227(90)90020-TPMID 2106423
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of various hypoglycaemic sulphonylureas on the cardiotoxicity of glycosides

  2004cited by this paper
• Antidiabetic sulfonylureas control action potential properties in heart cells via high affinity receptors that are linked to ATP-dependent K+ channels.

  1988cited by this paper
• AN ANALYSIS OF THE HAEMODYNAMIC EFFECTS OF TOLBUTAMIDE IN CONSCIOUS DOGS

  1988cited by this paper
• Differential Activities of Tolbutamide, Tolazamide, and Glyburide In Vitro on Rabbit Myocardial Membrane Ca2+-Transporting ATPase Activity

  1986cited by this paper
• The sulphonylurea receptor may be an ATP-sensitive potassium channel.

  1985cited by this paper
• The heart in diabetes.

  1984cited by this paper
• Tolbutamide and Glyburide Differ in Effectiveness to Displace α-and β-Adrenergic Radioligands in Pancreatic Islet Cells and Membranes

  1984cited by this paper
• Tolbutamide and glyburide differ in effectiveness to displace alpha- and beta-adrenergic radioligands in pancreatic islet cells and membranes.

  1984cited by this paper
• Coronary artery ligation, early arrhythmias, and determination of the ischemic area in conscious rats.

  1983cited by this paper
• Electrophysiological effects of hypoglycaemic sulphonylureas on rabbit heart.

  1980cited by this paper
• The direct effect of hypoglycaemic sulphonylureas on myocardial contractile force and arterial blood pressure

  1977cited by this paper
• Coronary care for myocardial infarction in diabetics.

  1974cited by this paper
• Tolbutamide-induced inotropic responses in the perfused working heart: effects of albumin.

  1973cited by this paper
• The effect of sulfonylurea drugs on rabbit myocardial contractility, canine purkinje fiber automaticity, and adenyl cyclase activity from rabbit and human hearts.

  1972cited by this paper
• Chlorpropamide-induced water retention in patients with diabetes mellitus.

  1971cited by this paper
• Enchancement of polyuria by glibenclamide in diabetes insipidus.

  1971cited by this paper
• The inhibitory effect of sulphonylurea derivatives on liver glycogenosis increased by catecholamines

  1970cited by this paper
• A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results.

  1970cited by this paper

• Tandem construction of biological relevant aliphatic 5-membered N-heterocycles.

  2022cites this paper
• Synthesis of new sulfamate linked 4-hydroxycoumarine conjugates as potent anti-α-amylase agents: In vitro approach coupled with molecular docking, DFT calculation and chemoinformatics prediction

  2022cites this paper
• Benzosuberene-sulfone analogues synthesis from Cedrus deodara oil and their therapeutic evaluation by computational analysis to treat type 2 diabetes.

  2021cites this paper
• Synthesis and hyperglycemic, biochemical and histopathological evaluation of novel sulfonylbiguanide and sulfonylurea derivatives as potent anti-diabetic agents.

  2021cites this paper
• Extraction and Evaluation of Mangifera indica Gum as a Sustained Release Polymer in Gliclazide Matrix Tablets

  2021cites this paper
• Evaluation of pharmacodynamics of ginger (Zingiber officinale) compared with gliclazide in diabetic rats

  2020cites this paper
• Synthesis, structural characterization and in vivo anti-diabetic evaluation of some new sulfonylurea derivatives in normal and silicate coated nanoparticle forms as anti-hyperglycemic agents.

  2019cites this paper
• Glucose Control: non-insulin therapies

  2018cites this paper
• Influence of Piracetam on Gliclazide—Glycated Human Serum Albumin Interaction. A Spectrofluorometric Study

  2018cites this paper
• Salts and Cocrystals of the Antidiabetic Drugs Gliclazide, Tolbutamide, and Glipizide: Solubility Enhancements through Drug–Coformer Interactions

  2017cites this paper
• Pro- and Antiarrhythmic Actions of Sulfonylureas: Mechanistic and Clinical Evidence.

  2017cites this paper
• FORMULATION DEVELOPMENT AND EVALUATION OF BIO-ADHESIVE CARBOPOL 974P NF POLYMER MATRIX BASED SUSTAINED RELEASE GLICLAZIDE TABLET

  2017cites this paper
• In Vitro Interaction Between Oral Hypoglycemic Drug And Herbal Sex Stimulants: Drug Interactions

  2016cites this paper
• SYNTHESIS, BIOLOGICAL EVALUATION AND MOLECULAR DOCKING STUDIES OF AROMATIC SULFONAMIDE DERIVATIVES AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS.

  2016cites this paper
• Dipeptidyl Peptidase-4 Inhibitors and Heart Failure: Friends or Foes?

  2015cites this paper
• PHARMACOKINETIC DRUG INTERACTIONS OF GLICLAZIDE AND ITOPRIDE IN NORMAL AND DIABETIC RATS

  2015cites this paper
• In vitro inhibition of AKR1Cs by sulphonylureas and the structural basis.

  2015cites this paper
• Glucose control: Non-insulin therapies

  2014cites this paper
• STATISTICAL CORRELATION AND QUANTIFICATION OF GLICLAZIDE BY SPECTROPHOTOMETRIC METHOD

  2014cites this paper
• In-Vitro Study of low viscosity, and high viscosity direct compression and conventional grade hypromellose for modified release gliclazide tablets

  2013influential citation
• The Role of Sulphonylureas in the Management of Type 2 Diabetes Mellitus

  2012cites this paper
• The 2012 SEMDSA Guideline for the Management of type 2 Diabetes

  2012cites this paper
• The 2012 SEMDSA Guideline for the Management of Type 2 Diabetes (Revised)

  2012cites this paper
• EFFICACY OF AYURVEDIC / HERBAL PATENT MEDICINES IN TYPE 2 DIABETES MELLITUS AS PER THE CLAIM

  2012cites this paper
• The 2012 SEMDSA Guideline for the Management of Type 2 Diabetes

  2012cites this paper
• Sarcolemmal KATP channel modulators and cardiac arrhythmias.

  2011cites this paper
• Diabetic cardiomyopathy: signaling defects and therapeutic approaches

  2010cites this paper
• Glimepiride upregulates eNOS activity and inhibits cytokine‐induced NF‐κB activation through a phosphoinoside 3‐kinase–Akt‐dependent pathway

  2009cites this paper
• Effectt of Diabetes Mellitus and its Treatmentt on Ventricular Arrhythmias Complicatingg Acute Myocardial Infarction n

  2008cites this paper
• Sulphonylureas and cardiovascular risk: facts and controversies

  2006cites this paper
• Review: Sulphonylureas and cardiovascular risk: facts and controversies

  2006cites this paper
• Effect of diabetes mellitus and its treatment on ventricular arrhythmias complicating acute myocardial infarction

  2005cites this paper
• Insulin, glucagon, and hypoglycemic drugs

  2003cites this paper
• Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data in humans and clinical applications.

  2003cites this paper
• New trends in the development of oral antidiabetic drugs.

  2002cites this paper
• Haemodynamic and Metabolic Effects of Low Daily Dose Sulphonylureas in Diabetic Dog Hearts

  2002cites this paper
• Glibenclamide effects on reperfusion-induced malignant arrhythmias and left ventricular mechanical recovery from stunning in conscious sheep.

  2001cites this paper
• Effects of the IK.ATP blockers glibenclamide and HMR1883 on cardiac electrophysiology during ischemia and reperfusion

  2000cites this paper
• Effects of the I(K.ATP) blockers glibenclamide and HMR1883 on cardiac electrophysiology during ischemia and reperfusion.

  2000cites this paper
• Relationship between blood glucose level and mortality in Type 2 diabetes mellitus: a systematic review

  1999cites this paper
• Relationship between ischaemia-selective drug action and antiarrhythmic efficacy

  1999cites this paper
• Comparison of the efficacy of glibenclamide and glimepiride in reperfusion-induced arrhythmias in rats.

  1999cites this paper
• Effect of Blood Glucose Concentrations on the Development of Chronic Complications of Diabetes Mellitus

  1998cites this paper
• Glibenclamide does not prevent action potential shortening induced by ischemia in anesthetized rabbits but reduces ischemia-induced arrhythmias.

  1998cites this paper
• KATP channel modulators increase survival rate during coronary occlusion-reperfusion in anaesthetized rats.

  1997cites this paper
• Exploiting complementary therapeutic strategies for the treatment of type II diabetes and prevention of its complications.

  1997cites this paper
• K channel modulators increase survival rate during coronary ATP occlusion-reperfusion in anaesthetized rats

  1997cites this paper
• United Kingdom Prospective Diabetes Study 17: A 9-Year Update of a Randomized, Controlled Trial on the Effect of Improved Metabolic Control on Complications in Non-Insulin-dependent Diabetes Mellitus

  1996cites this paper
• Haemodynamic and other effects of sulphonylurea drugs on the heart.

  1996cites this paper
• What kind of cardiovascular alterations could be influenced positively by oral antidiabetic agents?

  1996cites this paper
• Sulfonylurea KATP blockade in type II diabetes and preconditioning in cardiovascular disease. Time for reconsideration.

  1996cites this paper
• Effect of hypoglycemic sulphonylureas on vagal functions

  1996cites this paper
• ATP-sensitive potassium channel modulators: both pinacidil and glibenclamide produce antiarrhythmic activity during acute myocardial infarction in conscious rats.

  1996cites this paper
• Effects of tolbutamide on vascular ATP-sensitive potassium channels in humans. Comparison with literature data on glibenclamide and glimepiride.

  1996cites this paper
• Up-regulation of intracellular signalling pathways may play a central pathogenic role in hypertension, atherogenesis, insulin resistance, and cancer promotion--the 'PKC syndrome'.

  1996cites this paper
• Influence of hypoglycaemic sulphonylureas on the electrophysiological parameters of the heart.

  1996cites this paper
• Effects of Tolbutamide on Vascular ATP-Sensitive Potassium Channels in Humans

  1996cites this paper
• Potassium channels in the cardiovascular system.

  1995cites this paper
• Effect of moxonidine on arrhythmias induced by coronary artery occlusion and reperfusion.

  1994cites this paper
• Ion channels and diseases

  1994cites this paper
• INFLUENCE OF HYPOGLYCEMIC SULFONYLUREA COMPOUNDS ON THE INCIDENCE OF VENTRICULAR ECTOPIC BEATS IN NON-INSULIN-DEPENDENT DIABETIC PATIENTS TREATED WITH DIGITALIS

  1993cites this paper
• ATP‐sensitive K+ channels: Pharmacologic properties, regulation, and therapeutic potential

  1993cites this paper
• Effect of glimepiride on the electrical activity of isolated rabbit heart muscle.

  1992cites this paper
• Direct effect of hypoglycemic sulphonylureas on the cardiovascular system of dogs.

  1991cites this paper